Inventor · disambiguated record
Paul G. Abrams
Also filed as: ABRAMS PAUL G
21 granted patents·1,215 citations·filing 1984–2013
97Inventor score
Files withNEORX CORP16PONIARD PHARMACEUTICALS INC2DAMON BIOTECH INC1KASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LTD1
Top patents by PatentIndex Score
21 records- 0198US5169933ACovalently-linked complexes and methods for enhanced cytotoxicity and imagingNEORX CORP·Filed 1989·Granted Dec 8, 1992·409 cites·15 claims
- 0297US5112954AMethod of enhancing the effect of cytotoxic agentsNEORX CORP·Filed 1988·Granted May 12, 1992·147 cites·9 claims
- 0392US5135736ACovalently-linked complexes and methods for enhanced cytotoxicity and imagingNEORX CORP·Filed 1988·Granted Aug 4, 1992·98 cites·13 claims
- 0491USRE38008EMethods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereofNEORX CORP·Filed 2001·Granted Feb 25, 2003·42 cites·35 claims
- 0590US6767531B2High dose radionuclide complexes for bone marrow suppressionNEORX CORP·Filed 2001·Granted Jul 27, 2004·29 cites·13 claims
- 0690US5322678AAlteration of pharmacokinetics of proteins by charge modificationNEORX CORP·Filed 1988·Granted Jun 21, 1994·120 cites·11 claims
- 0790US4867962AFunctionally specific antibodiesNEORX CORP·Filed 1988·Granted Sep 19, 1989·73 cites·40 claims
- 0888US7070759B2High dose radionuclide complexes for bone marrow suppressionNEORX CORP·Filed 2005·Granted Jul 4, 2006·9 cites·29 claims
- 0987US7696331B2High dose radionuclide complexes for bone marrow treatmentPONIARD PHARMACEUTICALS INC·Filed 2008·Granted Apr 13, 2010·7 cites·9 claims
- 1085US5976535APretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful thereforeNEORX CORP·Filed 1995·Granted Nov 2, 1999·76 cites·3 claims
- 1184US7097823B2High dose radionuclide complexes for bone marrow suppressionNEORX CORP·Filed 2004·Granted Aug 29, 2006·13 cites·10 claims
- 1283US5034223AMethods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereofNEORX CORP·Filed 1987·Granted Jul 23, 1991·51 cites·31 claims
- 1377US4680174AInduction of immune response by immunization with encapsulated antigen-producing cellsDAMON BIOTECH INC·Filed 1984·Granted Jul 14, 1987·47 cites·30 claims
- 1476US7408046B2Treatment of bone-associated cancersPONIARD PHARMACEUTICALS INC·Filed 2004·Granted Aug 5, 2008·6 cites·20 claims
- 1575US5171563ACleavable linkers for the reduction of non-target organ retention of immunoconjugatesNEORX CORP·Filed 1992·Granted Dec 15, 1992·44 cites·34 claims
- 1669US5078673ASelective removal of radiolabeled antibodiesNEORX CORP·Filed 1989·Granted Jan 7, 1992·21 cites·32 claims
- 1758US8906344B2F-18 radiolabeled compounds for diagnosing and monitoring kidney functionKASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LTD·Filed 2013·Granted Dec 9, 2014·0 cites·30 claims
- 1853US5635180AAlteration of pharmacokinetics of proteins by charge modificationNEORX CORP·Filed 1995·Granted Jun 3, 1997·14 cites·11 claims
- 1938US5157104ATrichothecene conjugatesNEORX CORP·Filed 1988·Granted Oct 20, 1992·1 cites·15 claims
- 2035US5405966ATrichothecene conjugatesFiled 1993·Granted Apr 11, 1995·4 cites·7 claims
- 2133US4822734AMethod for improving the elicitation of IgG class monoclonal antibodies to tumor-associated antigens and glycoproteinsNEORX CORP·Filed 1985·Granted Apr 18, 1989·4 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →